Debevoise is advising TPG and OneOncology in the sale of TPG’s equity interest in OneOncology to Cencora (NYSE:COR) at an enterprise value of $7.4 billion. For more information, please see the company’s press release.

The Debevoise team is led by M&A partners Spencer Gilbert and Erik Andrén and includes associates Robert Geren, Luke Glavin, Richard Hughes and Matthew Ryan and law clerk Jason Bach, tax partners Michael Bolotin and Stephen Jordan and counsel Samuel Krawiecz, employee benefits and executive compensation partner Jonathan Lewis, counsel Kathleen Emberger and law clerk Annie Zhou, and antitrust partner Tim Cornell and associate Adam Saunders.